dr. choueiri on atezolizumab plus bevacizumab in non–clear cell rcc
Published 5 years ago • 87 plays • Length 1:06Download video MP4
Download video MP3
Similar videos
-
4:02
atezolizumab plus bevacizumab in non-clear cell, sarcomatoid kidney cancer
-
0:46
dr. rini discusses atezolizumab plus bevacizumab in rcc
-
1:51
dr. choueiri on ongoing trials of immunotherapy in rcc
-
1:14
dr. mcgregor on the combination of atezolizumab and bevacizumab in rcc
-
1:47
dr. choueiri discusses immunotherapy in rcc
-
1:47
dr. choueiri discusses avelumab/axitinib data in rcc
-
1:27
dr. rini on the tolerability of atezolizumab plus bevacizumab in rcc
-
1:41
dr. choueiri on next steps for treatment in rcc
-
0:52
dr. choueiri on impact of cabosun results in renal cell carcinoma
-
1:14
dr. jonasch on single-agent pembrolizumab in non-clear cell rcc
-
1:41
dr. atkins on results of atezolizumab plus bevacizumab in rcc
-
0:51
dr. choueiri discusses the cantata trial in rcc
-
2:30
dr. choueiri on the subgroup analysis of the javelin renal 101 trial in rcc
-
1:03
dr. pishvaian discusses atezolizumab plus bevacizumab in hcc
-
2:03
dr. choueiri on savolitinib in papillary renal cell cancer
-
2:09
dr. choueiri on biomarkers in rcc
-
1:47
dr. choueiri on the impact of the javelin renal 101 findings in rcc
-
1:35
dr. toni choueiri on cabozantinib versus everolimus in renal cell carcinoma
-
1:02
dr. choueiri on the research with immunotherapy in rcc